Xiangyu Medical Co.,Ltd (SHA:688626)

Xiangyu Medical Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	770.84	743.18	663.78	726.31	829.62	487.24
Trading Asset Securities	100.39	-	162.19	636.47	648.14	-
Cash & Short-Term Investments	871.23	743.18	825.98	1,363	1,478	487.24
Cash Growth	-6.01%	-10.02%	-39.39%	-7.78%	203.29%	33.75%
Accounts Receivable	74.25	67.7	57.99	34.35	43.03	32.74
Other Receivables	16.05	15.24	7.42	5	4.37	2.6
Receivables	90.3	82.95	65.41	39.35	47.4	35.34
Inventory	256.66	238.21	241.37	222.82	159.4	130.14
Prepaid Expenses	-	-	-	-	1.78	0.88
Other Current Assets	86.38	77.38	61.6	43.42	30.18	17.78
Total Current Assets	1,305	1,142	1,194	1,668	1,717	671.39
Property, Plant & Equipment	1,244	1,216	834.36	407.96	170.9	105.21
Long-Term Investments	23.29	23.37	258.52	17.09	16.71	2.55
Other Intangible Assets	215.16	216.89	207.7	204.25	208.78	51.62
Long-Term Accounts Receivable	-	-	47.79	43.03	50.2	29.88
Long-Term Deferred Tax Assets	7.85	9.55	11.22	14.7	11.4	9.12
Long-Term Deferred Charges	17.42	16.57	5.72	1.51	1.47	0.48
Other Long-Term Assets	295.02	303.32	32.47	11.15	6.57	111.28
Total Assets	3,107	2,928	2,592	2,368	2,183	981.53
Accounts Payable	91.1	135.81	109.69	103.87	27.71	14.92
Accrued Expenses	28.06	28.48	62.61	45.46	33.49	43.58
Short-Term Debt	580.2	354.1	27.02	17.15	-	50
Current Portion of Long-Term Debt	0.51	1.12	-	-	-	-
Current Income Taxes Payable	8.97	15.69	5.06	2.01	8.71	11.05
Current Unearned Revenue	137.85	127.97	107.56	135.69	64.23	50.08
Other Current Liabilities	72.46	71.54	60.21	47.62	47.27	30.38
Total Current Liabilities	919.14	734.71	372.14	351.8	181.42	200.01
Long-Term Leases	11.13	11.14	8.44	-	-	-
Long-Term Unearned Revenue	127.86	127.25	104.11	65.1	53.72	37.16
Long-Term Deferred Tax Liabilities	-	-	-	11.31	1.83	1.08
Total Liabilities	1,058	873.1	484.69	428.22	236.97	238.25
Common Stock	160	160	160	160	160	120
Additional Paid-In Capital	1,296	1,299	1,294	1,294	1,294	285.39
Retained Earnings	779	756.04	735.7	546.36	480.83	338.13
Treasury Stock	-201.83	-176.5	-98.93	-73.27	-	-
Total Common Equity	2,033	2,039	2,091	1,928	1,935	743.52
Minority Interest	15.52	16.1	16.53	12.27	10.53	-0.23
Shareholders' Equity	2,049	2,055	2,107	1,940	1,946	743.29
Total Liabilities & Equity	3,107	2,928	2,592	2,368	2,183	981.53
Total Debt	591.83	366.35	35.46	17.15	-	50
Net Cash (Debt)	279.39	376.83	790.52	1,346	1,478	437.24
Net Cash Growth	-55.75%	-52.33%	-41.25%	-8.94%	237.97%	20.03%
Net Cash Per Share	1.80	2.42	5.01	8.47	9.88	3.65
Filing Date Shares Outstanding	153.01	155.3	157.11	157.73	160	160
Total Common Shares Outstanding	153.01	155.3	157.11	157.73	160	120
Working Capital	385.43	407	822.21	1,317	1,535	471.38
Book Value Per Share	13.29	13.13	13.31	12.22	12.09	6.20
Tangible Book Value	1,818	1,822	1,883	1,723	1,726	691.9
Tangible Book Value Per Share	11.88	11.73	11.99	10.93	10.79	5.77
Buildings	-	-	326.28	96.84	96.84	96.84
Machinery	-	-	146.98	61.96	52.32	45.79
Construction In Progress	-	-	428.83	314.09	77.09	8.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.